Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)

Clinical trial NCT04303156 · COMPLETED

Trial details

NCT number: NCT04303156
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV) Infection

Start date: 2020-06-18
Primary completion: 2020-10-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.